Research Article
Prevalence and Antifungal Susceptibility Profile of Clinically Relevant Candida Species in Postmenopausal Women with Diabetes
Table 3
Antifungal susceptibility of the selected Candida species associated with postmenopausal women with diabetes.
| | Strains | Fluconazole | Voriconazole | Caspofungin | Micafungin | Amphotericin B | Flucytosine | | MIC | Interp. | MIC | Interp. | MIC | Interp. | MIC | Interp. | MIC | Interp. | MIC | Interp. |
| | Candida albicans MN419360 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419364 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419365 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419366 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419367 | ≥64 | R | ≥ 8 | R | ≥4 | R | ≥4 | R | ≥16 | R | 32 | R | | Candida albicans MN419369 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419371 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419372 | ≥64 | R | ≥8 | R | ≥4 | R | ≥4 | R | 8 | R | 32 | R | | Candida albicans MN419373 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419374 | ≤1 | S | 2 | I | ≤0.25 | S | ≤0.06 | S | 1 | S | ≤1 | S | | Candida albicans MN419376 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419378 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419389 | 4 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 1 | S | ≤1 | S | | Candida albicans MN419380 | 8 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 1 | S | ≤1 | S | | Candida albicans MN419381 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419384 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419385 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida albicans MN419387 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida glabrata MN419362 | 8 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 2 | I | ≤1 | S | | Candida glabrata MN419363 | 4 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | ≤0.25 | S | ≤1 | S | | Candida glabrata MN419368 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida glabrata MN419389 | ≤1 | S | ≤0.12 | S | ≤0.25 | S | ≤0.06 | S | 0.5 | S | ≤1 | S | | Candida krusei MN419370 | ≥64 | R | ≥8 | R | ≥4 | R | ≥4 | R | ≥16 | R | ≥64 | R | | Candida krusei MN419388 | 32 | R | ≤0.12 | S | ≤0.25 | S | ≤0.12 | S | 0.5 | S | 8 | R |
|
|
S = susceptible; I = intermediate; R = resistance; MIC = minimum inhibition concentration; Inter = interpretation.
|
